The new year is already shaping up to be an exciting one for media coverage. As we continue pushing the boundaries of consumer longevity science, I’ve been fortunate to receive recognition from leading publications—including Forbes, Business Traveler, and Fitt Insider. Their latest features highlight how far we’ve come in our mission to help people slow aging and live healthier, longer lives. Here are some quick summaries and links to each piece.
Forbes: How Entrepreneurs Are Turning Longevity Into a Multi-Billion Opportunity
Read the full article here
Forbes explored the booming longevity industry, where companies are racing to bring evidence-backed anti-aging interventions to consumers. The article discusses how major players like Bryan Johnson are making headlines with extravagant approaches to longevity, while others—like NOVOS—are taking a more scientifically rigorous path.
The Forbes author states, “In a sea of generic supplement suppliers with just a packaging and marketing department, NOVOS’ commitment to research is a clear outlier.”
In the piece, I emphasized how NOVOS sets itself apart from most supplement brands, which are often “marketing machines first and foremost.” Unlike companies that simply copy existing formulas, we prioritize research and validation. The article highlights how our study on aged mice demonstrated a greater increase in lifespan than any supplement ever tested—even outperforming many pharmaceutical R&D treatments. Additionally, our human case study found that 73% of participants slowed their biological pace of aging, with 0% accelerating.
With so many brands making unverified claims, Forbes recognized NOVOS as a company raising the bar for transparency and scientific rigor in the longevity space.
Business Traveler: Athletes, Celebrities, and CEOs Use These Products to Stay Young
Read the full article here
Business Traveler took a deep dive into the products and services top entrepreneurs and athletes are using to optimize their health. Among them? NOVOS Core.
Described as “the first scientifically validated solution that tackles the 12 root causes of aging,” NOVOS Core was highlighted for its unique formulation and impressive results. The article notes that 73% of users see reductions in aging within just six months, with many customers outperforming even the most extreme longevity enthusiasts—like Bryan Johnson—on the Rejuvenation Olympics leaderboard.
While some competitors push unproven “quick fixes,” we’ve focused on habit-forming, science-backed interventions that fit into people’s daily routines. As I shared with Business Traveler, “It’s not about downing 19 pills—it’s about sustainable longevity.”
Fitt Insider: Q&A With Chris Mirabile, Founder & CEO of NOVOS
Read the full article here
Fitt Insider published an in-depth Q&A with me, covering my personal journey with longevity, the science behind NOVOS, and where we’re headed next.
I spoke about my brain tumor diagnosis at 16, which fueled my lifelong commitment to health optimization. That experience led me to realize that true health isn’t about short-term aesthetics—it’s about slowing the biological processes that lead to disease and decline.
The article details how NOVOS is more than just a supplement company—it’s a consumer longevity biotech with a growing tech ecosystem. We discussed how our offerings have expanded to include:
- NOVOS Age – a blood-based biological age test
- NOVOS FaceAge – an AI-driven facial aging analysis
- NOVOS Life – an app that delivers personalized AI-driven longevity insights
With 10 million doses sold and thousands of five-star reviews, Fitt Insider recognized NOVOS as a leader in the longevity industry.
Closing Thoughts
As we step into 2025, these articles reinforce what we at NOVOS have always believed: longevity isn’t just for billionaires. With the right science and commitment, everyday people can take control of their aging and live longer, healthier lives.
I’m grateful for the recognition from Forbes, Business Traveler, and Fitt Insider, and I encourage you to check out their full articles to learn more.